C4 Therapeutics annual debt-to-assets ratio
2019
2020
2021
2022
2023
2024
2025
C4 Therapeutics Debt-to-Assets Ratio Growth & History (CCCC)
C4 Therapeutics's debt-to-assets ratio was 0.17 for fiscal 2025.
View full C4 Therapeutics company overviewC4 Therapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.17 | −0.02 | −11.19% |
| 2024 | 2024-12-31 | 0.19 | −0.00 | −0.24% |
| 2023 | 2023-12-31 | 0.19 | −0.01 | −6.79% |
| 2022 | 2022-12-31 | 0.20 | 0.12 | +139.07% |
| 2021 | 2021-12-31 | 0.08 | 0.03 | +47.72% |
| 2020 | 2020-12-31 | 0.06 | −0.06 | −50.73% |
| 2019 | 2019-12-31 | 0.12 | — | — |
C4 Therapeutics quarterly debt-to-assets ratio
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.16 | −0.05 | −25.45% |
| Q1 2026 | 2026-03-31 | 0.18 | −0.02 | −11.77% |
| Q4 2025 | 2025-12-31 | 0.17 | −0.02 | −11.19% |
| Q3 2025 | 2025-09-30 | 0.23 | 0.05 | +29.76% |
| Q2 2025 | 2025-06-30 | 0.21 | 0.03 | +18.20% |
| Q1 2025 | 2025-03-31 | 0.20 | 0.03 | +15.10% |
| Q4 2024 | 2024-12-31 | 0.19 | −0.00 | −0.24% |
| Q3 2024 | 2024-09-30 | 0.18 | −0.04 | −17.69% |
| Q2 2024 | 2024-06-30 | 0.18 | −0.04 | −19.57% |
| Q1 2024 | 2024-03-31 | 0.18 | −0.04 | −18.89% |
| Q4 2023 | 2023-12-31 | 0.19 | −0.01 | −6.79% |
| Q3 2023 | 2023-09-30 | 0.22 | 0.03 | +13.59% |
| Q2 2023 | 2023-06-30 | 0.22 | 0.05 | +27.35% |
| Q1 2023 | 2023-03-31 | 0.22 | 0.05 | +27.23% |
| Q4 2022 | 2022-12-31 | 0.20 | 0.12 | +139.07% |
| Q3 2022 | 2022-09-30 | 0.19 | 0.15 | +327.26% |
| Q2 2022 | 2022-06-30 | 0.18 | 0.13 | +306.75% |
| Q1 2022 | 2022-03-31 | 0.17 | 0.11 | +177.61% |
| Q4 2021 | 2021-12-31 | 0.08 | 0.03 | +47.72% |
| Q3 2021 | 2021-09-30 | 0.04 | −0.06 | −55.46% |
| Q2 2021 | 2021-06-30 | 0.04 | — | — |
| Q1 2021 | 2021-03-31 | 0.06 | — | — |
| Q4 2020 | 2020-12-31 | 0.06 | −0.06 | −50.73% |
| Q3 2020 | 2020-09-30 | 0.10 | — | — |
| Q4 2019 | 2019-12-31 | 0.12 | — | — |
C4 Therapeutics debt-to-assets ratio trends
Over the last five fiscal years, C4 Therapeutics's debt-to-assets ratio increased from 0.06 to 0.17, a change of 0.11. The latest reported quarter, Q2 2026, shows 0.16.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review C4 Therapeutics source filings ↗